Evidence map›Paper›PMID 31096821›Full record

ArticleInnate immunity2019

Pioglitazone improves phagocytic activity of liver recruited macrophages in elderly mice possibly by promoting glucose catabolism.

Masahiro Nakashima, Manabu Kinoshita, Hiroyuki Nakashima, Aya Kotani, Takuya Ishikiriyama, Shoichiro Kato, Sadayuki Hiroi, Shuhji Seki

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Innate immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Pioglitazone Modifies Kupffer Cell Function and Protects againstInternational journal of molecular sciences · 2022
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Masahiro Nakashima1 Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, Japan.ORCID 0000-0003-4385-5802
Manabu Kinoshita1 Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, Japan.
Hiroyuki Nakashima1 Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, Japan.
Aya Kotani1 Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, Japan.
Takuya Ishikiriyama1 Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, Japan.
Shoichiro Kato2 Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.
Sadayuki Hiroi3 Department of Pathology, Nitobebunka College, Nakano, Tokyo, Japan.
Shuhji Seki1 Department of Immunology and Microbiology, National Defense Medical College, Tokorozawa, Japan.
National Defense Medical College · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgingAnimalsCD11b AntigenCytokinesEscherichia coliEscherichia coli InfectionsGlucoseInflammation MediatorsLiverMacrophagesMaleMiceMice, Inbred C57BLPhagocytosisPioglitazonePPAR gammaCD11b AntigenCytokinesGlucoseInflammation MediatorsPioglitazonePPAR gammaReactive Oxygen SpeciesAgingglycolysisliverphagocytosisrecruited macrophage

Identifiers

PMID31096821
PMCPMC7103614
OpenAlexW2946323016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.